Cargando…
Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery
OBJECTIVES: The ongoing COVID-19 pandemic comprises a total of more than 2,350,000 cases and 160,000 deaths. The interest in anti-coronavirus drug development has been limited so far and effective methods to prevent or treat coronavirus infections in humans are still lacking. Urgent action is needed...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
L'Encéphale, Paris.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188634/ https://www.ncbi.nlm.nih.gov/pubmed/32387014 http://dx.doi.org/10.1016/j.encep.2020.04.010 |